ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Committee Discusses Cap On Center Grants, New Guidelines

October 18, 1991

Peter Boyle Elected IARC Director

May 23, 2003

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

NCI Cooperative Group, Cancer Center Trials Listed

September 26, 2008

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984